Medin-amyloid: A recently characterized age-associated arterial amyloid form affects mainly arteries in the upper part of the body

Amyloid

Volumn 12, Issue 2, 2005, Pages 96-102

  Peng, Siwei ^a   Glennert, Johanna ^a   Westermark, Per ^a,b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Amyloid; Aneurysm; Aorta; Arteries; Lactadherin

Indexed keywords

AMYLOID; LACTADHERIN; PROTEIN MEDIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BASILAR ARTERY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MUSCLE CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TEMPORAL ARTERY; THORACIC AORTA; TUNICA MEDIA; VASCULAR SMOOTH MUSCLE;

AGED; AGED, 80 AND OVER; AGING; ANTIGENS, SURFACE; ARTERIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MILK PROTEINS; UPPER EXTREMITY;

EID: 22144483471     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506120500107006     Document Type: Article

References (33)

1. Gertz MA, Kyle RA. Primary systemic amyloidosis-a diagnostic primer Mayo Clin Proc 1989;64:1505-1519.
2. Westermark P, Johansson B, Natvig JB. Senile cardiac amyloidosis: evidence of two different amyloid substances in the aging heart. Scand J Immunol 1979;10:303-308.
3. Revesz T, Holton JL, Lashley T, Plant G, Rostagno A, Ghiso J, et al. Sporadic and familial cerebral amyloid angiopathies. Brain Pathol 2002;12:343-57.
4. Schwartz P. New patho-anatomic observations on amyloid in the aged. Fluorescence microscopic investigations. In: Mandema E, Ruinen L, Scholten JH, Cohen AS, editors. Amyloidosis. Amsterdam: Excerpta Medica; 1968. pp 400-415.
5. Battaglia S, Trentini GP. Aortenamyloidose im Erwachsenalter. Virchows Arch A 1978;378:153-159.
6. Cornwell GG III, Westermark P, Murdoch W, Pitkänen P. Senile aortic amyloid. A third distinctive type of age-related cardiovascular amyloid. Am J Pathol 1982;108:135-139.
7. Cornwell GG III, Murdoch WL, Kyle RA, Westermark P, Pitkänen P. Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 1983;75:618-23.
8. Mucchiano G, Cornwell GG III, Westermark P. Senile aortic amyloid. Evidence of two distinct forms of localized deposits. Am J Pathol 1992;140:871-877.
9. Couto JR, Taylor MR, Godwin SG, Ceriani RL, Peterson JA. Cloning and sequence analysis of human breast epithelial antigen BA46 reveals an RGD cell adhesion sequence presented on an epidermal growth factor-like domain. DNA Cell Biol 1996;15:281-286.
10. Andersen MH, Graversen H, Fedosov SN, Petersen TE, Rasmussen JT. Functional analyses of two cellular binding domains of bovine lactadherin. Biochemistry 2000;39:6200-6206.
11. Häggqvist B, Näslund J, Sletten K, Westermark GT, Mucchiano G, Tjernberg LO, et al. Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. Proc Natl Acad Sci USA 1999;96:8669-8674.
12. Newburg DS, Peterson JA, Ruiz-Palacios GM, Matson DO, Morrow AL, Shults J, et al. Role of human-milk lactadherin in protection against symptomatic rotavirus infection. Lancet 1998;351:1160-1164.
13. Andersen MH, Berglund L, Rasmussen JT, Petersen TE. Bovine PAS-6/7 binds αvβ5 integrin and anionic phospholipids through two domains. Biochemistry 1997;36:5441-5446.
14. Peng S, Westermark GT, Näslund J, Häggqvist B, Glennert J, Westermark P. Medin and medin-amyloid in aging inflamed and non-inflamed temporal arteries. J Pathol 2002;196:91-96.
15. Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid binding sites. Blood 2003;101:2628-2636
16. Puchtler H, Sweat F, Levine M. On the binding of Congo red by amyloid. J Histochem Cytochem 1962;10:355-364.
17. Mucchiano GI, Häggqvist B, Sletten K, Westermark P. Apolipoprotein A-1-derived amyloid in atherosclerotic plaques of the human aorta. J Pathol 2001;193:270-275.
18. Bergström J, Murphy CL, Weiss DT, Solomon A, Sletten K, Hellman U, et al. Two different types of amyloid deposits-apolipoprotein A-IV and transthyretin-in a patient with systemic amyloidosis. Lab Invest 2004;84:981-988.
19. Kononen J, Bubendorf L, Kallioniemi A, Barlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nature Med 1998;4:844-847.
20. Giuffrida MG, Cavaletto M, Giunta C, Conti A, Godovac-Zimmermann J. Isolation and characterization of full and truncated forms of human breast carcinoma protein BA46 from human milk fat globule membranes. J Protein Chem 1998;17:143-148.
21. Schagger A, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-379.
22. Haan J, Hardy JA, Roos RA. Hereditary cerebral hemorrhage with amyloidosis-Dutch type: its importance for Alzheimer research. Trends Neurosci 1991;14:231-234.
23. Levy E, Carman MD, Fernandez-Madrid IJ, Power MD, Lieberburg I, van Duinen SG, et al. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990;248:1124-1126.
24. Luyendijk W, Bots GT, Vegter-van der Vlis M, Went LN, Frangione B. Hereditary cerebral hemorrhage caused by cortical amyloid angiopathy. J Neurol Sci 1988;85:267-280.
25. Iwamoto N, Ishihara T, Ito H, Uchino F. Morphological evaluation of amyloid-laden arteries in leptomeninges, cortices and subcortices in cerebral amyloid angiopathy with subcortical hemorrhage. Acta Neuropathol 1993;86:418-421.
26. Greene GM, Godersky JC, Biller J, Hart MN, Adams HP. Surgical experience with cerebral amyloid angiopathy. Stroke 1990;21:1545-1549.
27. Vinters HV. Cerebral amyloid angiopathy. A critical review. Stroke 1987;18:311-324.
28. Winkler DT, Bondolfi L, Herzig MC, Jann L, Calhoun ME, Wiederhold KH, et al. Spontaneous hemorrhagic stroke in a mouse model of cerebral amyloid angiopathy. J Neurosci 2001;21:1619-1627.
29. Prior R, D'Urso D, Frank R, Prikulis I, Pavlakovic G. Loss of vessel wall viability in cerebral amyloid angiopathy. Neuroreport 1996;7:562-564.
30. Lorenzo A, Razzaboni B, Weir GC, Yankner BA. Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus. Nature 1994;368:756-760.
31. Schubert D, Behl C, Lesley R, Brack A, Dargusch R, Sagara Y, et al. Amyloid peptides are toxic via a common oxidative mechanism. Proc Natl Acad Sci USA 1995;92:1989-1993.
32. Janson J, Ashley RH, Harrison D, McIntyre S, Butler PC. The mechanism of islet amyloid polypeptide toxicity is membrane disruption by intermediate-sized toxic amyloid particles. Diabetes 1999;48:491-498.
33. Anders KH, Wang ZZ, Kornfeld M, Gray F, Soontornniyomkij V, Reed LA, et al. Giant cell arteritis in association with cerebral amyloid angiopathy:Immunohistochemical and molecular studies. Hum Pathol 1997;28:1237-1246